Regenstrief and Boomerang Ventures partner to expand the reach of healthcare innovations

Regenstrief Institute and Boomerang Ventures are announcing a partnership to develop and disseminate healthcare solutions to improve the well-being of people around the world. The new partnership will enable Regenstrief to expand the reach of its innovations, and Boomerang Ventures will benefit from the expertise of the institute's research scientists.

Regenstrief Institute is a global leader dedicated to improving health and healthcare through innovations and research in biomedical informatics, health services and aging. Boomerang Ventures is a venture fund and studio that works to build, launch and fund new companies and concepts to help improve healthcare. Together, they will work to develop and commercialize innovations from Regenstrief research scientists, making them more widely available and more impactful.

By engaging Regenstrief scientists early in the research process to assist them in building and scaling healthcare solutions beyond the grant funding cycle, Boomerang Ventures can help navigate risks and regulations and build relationships with other partners to create a successful and innovative ecosystem.

"Bringing even well thought out, evidence-backed concepts to market can be complex. With its depth and expertise, Boomerang Ventures will help us take the discoveries made in our research to the next stage, refining and connecting these promising concepts to professionals and markets to help them flourish," said Todd Saxton, PhD, Regenstrief vice president for business development. "It is one promising approach in an array of ways to move from research to impact. We look forward to working closely with Boomerang Ventures to advance our research for the betterment of people's health and healthcare systems."

Boomerang Ventures will rely on expertise, experience and knowledge of Regenstrief experts in other ventures as well.

Regenstrief and its scientists are well known for their rigorous research, analysis and evaluation. We look forward to this partnership as we work to guide the implementation of these healthcare innovations. This partnership will help bridge the gap between research and the business world by combining Regenstrief's tremendous talent with the expertise, collaboration and other resources we can contribute to scale healthcare-revolutionizing products into the marketplace."

Oscar Moralez, Managing Partner, Boomerang Ventures


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
UK HealthCare neurologist helps to compile an essential list of MS medications